Good pharmacists..โš•๐Ÿ“š๐Ÿ‘จโ€โš•
1.18K subscribers
100 photos
3 videos
13 files
183 links
๐Ÿ”ฐ ู‚ู†ุงู‡ ุชุญุชูˆูŠ ุนู„ู‰ ู…ุนู„ูˆู…ุงุช_ ุทุจูŠุฉ ุญูˆู„ ุงู„ุงุฏูˆูŠู‡ ูˆุชุดุฎูŠุต ุงู„ุญุงู„ุงุช ุงู„ุณุฑูŠุฑูŠุฉ..๐Ÿ’Š๐Ÿ’‰๐Ÿ‘จโ€โš•.

ุฑุงุจุท ุงู„ู‚ู†ุงุฉ..
https://t.me/pharma_Note

ู„ู„ุชูˆุงุตู„ ู…ุน ุงู„ุฃุฏู…ู† :
@Basel_Alafif
Download Telegram
๐Ÿ›‘ู„ู„ุชุฐูƒูŠุฑ:

ุชูˆู‚ู ุนู† ุงุณุชุฎุฏุงู… Orlistat ุงุฐุง ู„ู… ูŠูู‚ุฏ ุงู„ู…ุฑูŠุถ %5 ู…ู† ูˆุฒู†ู‡ ุฎู„ุงู„ 12 ุงุณุจูˆุน ู…ู† ุงู„ุงุณุชุฎุฏุงู….

#Basel
๐Ÿ‘8
๐Ÿ›‘Vancomycin

๐Ÿ’ ู…ู…ูƒู† ูŠุนู…ู„ ุญุงุฌุชูŠู† ูˆุงู„ูƒู„ ูŠุนุฑูู‡ู…ุŒุจุณ ุงู„ุจุนุถ ูŠู‚ุฏุฑ ูŠูุฑู‚ ุจูŠู†ู‡ู…:
โœ…hypersensitivity (allergic reaction) or
โœ…anaphylactoid( non allergic reaction)

โœ…ูุงู„ุงูˆู„ู‰ ู†ุงุชุฌุฉ Ab-Ag reaction

โœ…ุจูŠู†ู…ุง ุงู„ุฃุฎุฑ ู†ุงุชุฌุฉ ู…ู† ุฒูŠุงุฏุฉ ู…ุนุฏู„ ุงู„ infusion rate
ูˆุชุธู‡ุฑ ู…ุง ูŠุณู…ู‰
RMS( red man syndrome)
ูˆู†ุนุฑู ุงู„ุงุนุฑุงุถุŒ ูˆู„ุง ูŠุณุชุจุนุฏ ุงู„ุงุณู… ุงู„woman ู†ู†ุชุจู‡๐ŸŒš

๐Ÿ’ ุทูŠุจ ู„ูŠุด ู…ู‡ู… ุงู„ูุฑู‚ุŸ

โœ…ู„ุฃู†ู‡ ููŠ ุญุงู„ ุญุตู„ุช ู…ุน ุงู„ู…ุฑูŠุถ ุงู„ุญุงู„ุฉ ุงู„ุฃูˆู„ู‰ ู…ู…ู†ูˆุน ูŠุนุทู‰ ู„ู‡ ู…ุฑุฉ ุซุงู†ูŠุฉ ูˆูŠุนุชุจุฑ absolute contraindication

โœ…ุงู…ุง ู„ูˆ ุญุตู„ุช ุงู„ุงุฎุฑ ูุญู„ู‡ุง ู‡ูˆ ุชุจุทุฆู‡ ู…ุนุฏู„ ุงู„ุฃุฎุฐ ูุงู„ู…ูุฑูˆุถ ูƒู„ ุฌุฑุงู… ูŠุนุทู‰ ู„ู…ุฏุฉ ุณุงุนุฉุŒ ูˆู„ูƒู† ูˆุฌุฏูˆุง ูƒู…ุงู† ุงู†ู‡ ููŠ ู†ุงุณ ุชุญุตู„ ู…ุนู‡ู… ุญุชู‰ ู„ูˆ ุงู„ุฑูŠุช ู…ุด ุนุงู„ูŠุŒ ู„ุฐู„ูƒ ุงุญูŠุงู†ุง ูŠุนุทู‰ anti histamine ู‚ุจู„ ู…ุซู„ diphenhydramine ู„ุชู‚ู„ูŠู„ ุญุฏูˆุซู‡ุง.

๐Ÿ’ ุงู…ุง ุนู† ุงู„ุณุจุจุŸ

โœ…ูุงู„ุงูˆู„ู‰ ูƒู…ุง ุฐูƒุฑู†ุง ุณุจุจู‡ุง Ab-Ag reaction

โœ…ุงู…ุง ุงู„ุงุฎุฑ ูู†ุธุฑุง ู„ุงู† ุงู„ุฏูˆุงุก basic structure ูˆู„ู‡ affinity ุนุงู„ูŠุฉ ุงู†ู‡ ูŠุฑูˆุญ ูŠู…ุณูƒ ุจุงู„ mast cell ุงู„ู…ู…ู„ุคุฉ ุจุงู„ู‡ุณุชุงู…ูŠู† ูˆุงู„ู…ุณุคูˆู„ู‡ ุนู† ุงูุฑุงุฒู‡ุŒ ูู„ู…ุง ูŠุฏุฎู„ ุงู„ุฏูˆุงุก ูˆุชุถูŠู‚ ุงู„ู…ุณุงุญุฉ ุฏุงุฎู„ ุงู„mast ุชู‚ูˆู… ุชุฎุฑุฌ ุงู„ู‡ุณุชุงู…ูŠู† ูˆู‡ูˆ ุงู„ุณุจุจ ููŠ ุงู„ุฃุนุฑุงุถ ุงู„ุชู‰ ุชุธู‡ุฑ.

ููƒู„ู…ุง ูƒุงู† ุงู„ุฑูŠุช ุนุงู„ูŠ ุจุฏู„ ู…ุง ูŠุชูˆุฒุน ุงู„ุฏูˆุงุก ู„ู„ุฃู†ุณุฌุฉ ูŠุฑูˆุญ mast cell ู„ุฐู„ูƒ ุงู„ุญู„ ู†ู‚ู„ู„ ุงู„ุฑูŠุช.


๐Ÿ’ ุทูŠุจ ุงู„ุฃู‡ู… ูƒูŠู ู†ุนุฑู ู†ูุฑู‚ุŸ

โœ…ุงู…ุง ู…ู† history ุงู†ู‡ ุญุตู„ ู…ู† ู‚ุจู„ุŒูˆู„ูˆ ุงูˆู„ ู…ุฑุฉ ูŠุฃุฎุฐ ุงู„ุฏูˆุงุก ูˆุญุตู„ุช ูู‡ูŠุง red man syndrome ู„ุงู†ู‡ ู…ุงู‚ุฏ ุชูƒูˆู†ุชAb ุถุฏู‡

โœ…ุงุฎุชุจุงุฑ ุญุณุงุณูŠุฉ ุชุญุช ุงู„ุฌู„ุฏ.

#Basel
https://t.me/pharma_Note
๐Ÿ‘3โค2
ุงู„ู…ู„ุฎุต..
๐Ÿ’ ููŠ ู‡ุฐู‡ ุงู„ุฏุฑุงุณุฉ ุŒ ุฃุซุจุชุช LDC ุงู„ูŠ ู‡ูŠ low dose combination ู…ุน 3 ุฃูˆ 4 ู…ุถุงุฏุงุช ู„ุงุฑุชูุงุน ุงู„ุถุบุท ุงู„ุฏู…ูˆูŠ ุฃู†ู‡ ุนู„ุงุฌ ูุนุงู„ ูˆู…ุชุญู…ู„ ุฌูŠุฏู‹ุง ู„ุชุฎููŠุถ ุถุบุท ุงู„ุฏู… ููŠ ุงู„ู…ุนุงู„ุฌุฉ ุงู„ุฃูˆู„ูŠุฉ ู„ุงุฑุชูุงุน ุถุบุท ุงู„ุฏู… ุชูˆูุฑ ู…ุถุงุฏุงุช ุงู„ุงุฑุชูุงุน ููŠ ุถุบุท LDC ุญู„ู‹ุง ููŠ ุฎุทูˆุฉ ูˆุงุญุฏุฉ ุชู…ุช ุฅุซุจุงุชู‡ ู„ุชุญู‚ูŠู‚ ู…ุนุฏู„ุงุช ุณูŠุทุฑุฉ ุนู„ู‰ ุถุบุท ุงู„ุฏู… ุงู„ู…ุณุชู…ุฑ ุจู†ุณุจุฉ %70ูˆู‡ูˆ ุชู‚ุฏู… ุนู„ุงุฌูŠ ู‡ุงู…. ูˆู…ุน ุฐู„ูƒ ุŒ ู„ุชุญู‚ูŠู‚ ู…ุนุฏู„ุงุช ุณูŠุทุฑุฉ ุทูˆูŠู„ุฉ ุงู„ุฃุฌู„ ุจู†ุณุจุฉ ุฃุนู„ู‰ ู…ู† ุฐู„ูƒ ุŒ ูŠุชุทู„ุจ ุงู„ุฃู…ุฑ ุจุญุซู‹ุง ุฃูƒุซุฑ ุญูˆู„ ุฃูุถู„ ุงุณุชุฑุงุชูŠุฌูŠุฉ ู„ุชูƒุซูŠู ุงู„ุนู„ุงุฌ ุจุดูƒู„ ู‚ุงุจู„ ู„ู„ุชุญู…ู„ ู„ู„ุฃุดุฎุงุต ุงู„ุฐูŠู† ูŠุชู†ุงูˆู„ูˆู† LDCs.

๐Ÿ’ ู„ุฐู„ูƒ ุญุชู‰ ุงู„ุงู† ุงู„ุฌุงูŠุฏู„ุงูŠู†ุฒ ุชูˆุตูŠ ุจุฃุฎุฐ hypertension polypills ุงู„ูŠ ุชุญุชูˆูŠ ุน ุงูƒุซุฑ ู…ู† ุฏูˆุงุก ุจุชุฑุงูƒูŠุฒ ู…ู†ุฎูุถุฉุŒ ูุฃุฎุชู„ุงู ุขู„ูŠุฉ ุงู„ุนู…ู„ ู„ูƒู„ ุฏูˆุงุก ูŠุนุทูŠ ูุนุงู„ูŠุฉ ุงู‚ูˆู‰ุŒูˆุงูŠุถุง ุงุณุฑุน ููŠ ุงู„ูˆุตูˆู„ ู„ู„ู‡ุฏู ุงู„ุนู„ุงุฌูŠุŒูˆูƒุฐู„ูƒ ุชู‚ู„ู„ ู…ู† ุงู„ุขุซุงุฑ ุงู„ุฌุงู†ุจูŠุฉ.
๐Ÿ’  ูˆู‡ุฐู‡ ุฏุฑุงุณุฉ ุงุซุจุชุช ุฐู„ูƒ
RCT: Initial hypertension treatment with a single pill with 4 drugs at quarter doses (irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, and bisoprolol 2.5 mg) achieved better BP lowering vs. standard monotherapy (irbesartan 150 mg)

#Basel
https://t.me/pharma_Note
๐Ÿ‘1
โญ•๏ธุนุดุงู† ู…ุงููŠ ุนู†ุฏู†ุง polypills ูˆ ูˆู…ู…ูƒู† ู…ุง ุชุฌูŠ ุญุชู‰ ๐ŸŒš
ุงู„ู…ู‡ู… ู‡ูŠ ุงู„ู…ู„ุงุญุธู‡ ุงู„ุชุงู„ูŠุฉ..!

โœ…ุงู† ุฑูุน ุฌุฑุนุฉ ุงู„ุฏูˆุงุก ูˆุญูŠุฏ ููŠ ุนู„ุงุฌ ุงู„ุถุบุท ูŠุฒูŠุฏ ู…ู† ุงู„ุขุซุงุฑ ุงู„ุฌุงู†ุจูŠุฉ ุงูƒุซุฑ ุงู…ุง ูุนุงู„ูŠุชู‡ ููŠ ุชู‚ู„ู„ ุงู„ุถุบุท ูู„ู† ุชุฒูŠุฏ ูƒุซูŠุฑุง ุจู…ุนู†ู‰.!

โœ…ูู…ุซู„ุง ู„ูˆ ู…ุฑูŠุถ ู…ุงุดูŠ amlodipine 5mg
ูˆู„ู… ูŠุนูŠุฏ ุชุญุช ุงู„ุณูŠุทุฑุฉ ูู…ู† ุงู„ุงูุถู„ ุงุถุงูุฉ ุฏูˆุงุก ุงุฎุฑ ุนู† ุฑูุน ุฌุฑุนุชู‡ ุงู„ู‰ 10mg
ูุงู„ูุงุฑู‚ ููŠ ุงู„ุฌุฑุนุฉ ู„ู† ูŠู‚ู„ู„ ุงู„ุถุบุท ุงู„ู‰ ุงู„ุดูƒู„ ุงู„ู…ุทู„ูˆุจุŒูˆู…ู† ุงู„ุฃูุถู„ ุงุถุงูุฉ ุฏูˆุงุก ุงุฎุฑ.

#Basel
https://t.me/pharma_Note
๐Ÿ‘3
โœ…ููŠ ู…ู‚ุงู„ ู‚ุฑุฃุชู‡ุง ุงู„ูŠูˆู… ูŠุชูƒู„ู… ุนู† ุฃุฏูˆูŠุฉ ุงู„ุถุบุท ูˆุงู„ุนู„ุงู‚ุฉ ุจูŠู†ู‡ุง ูˆุจูŠู† ุงู„dementia ุงู„ูŠ ูŠูƒูˆู† ูƒุซูŠุฑุง ู…ุน ูƒุจุงุฑ ุงู„ุณูƒู†ุŒ ูˆุฌุฏูˆุง ุงุฏูˆูŠุฉ ุชู‚ู„ู„ risk ู„ู‡ุง ุจู†ุณุจุฉ ุชุตู„ ุงู„ู‰ %40 ูˆู„ูƒู† ู…ุด ูƒู„ ุฃุฏูˆูŠุฉ ุงู„ุถุบุท..!

ูุชุจุนุงู‹ ู„ุฃู„ูŠุฉ ุนู…ู„ ูƒู„ ู…ุฌู…ูˆุนุฉ ุน ุงู„ุงู†ุฌูŠูˆุชู†ุณูŠู† ุงูˆ ู…ุง ูŠุณู…ู‰ (ู†ุธุฑูŠุฉ ุงู„ุงู†ุฌูŠูˆุชู†ุณูŠู†) ู‚ุณู…ูˆุง ุงู„ุฃุฏูˆูŠุฉ ุงู„ู‰ ู…ุฌู…ูˆุนุชูŠู†..
โœ…angiotensin IIโ€“stimulating antihypertensives
ู…ุซู„..
(thiazides, dihydropyridine
calcium channel blockers, and angiotensin I receptor blockers)

โœ… angiotensin IIโ€“inhibiting antihypertensives

ู…ุซู„..
(angiotensin-converting
enzyme inhibitors, ฮฒ-blockers, and nondihydropyridine calcium channel blockers)

โœ…ู„ุฐู„ูƒ ูƒุงู† ููŠ compelling indication ู„ู…ู†ุน ุงู„dementia ุนู†ุฏ ูƒุจุงุฑ ุงู„ุณู† ุงู„ู…ุตุงุจูŠู† ุจู…ุฑุถ ุงู„ุถุบุท..

ูˆู„ุฐู„ูƒ ู†ุฌุฏ ุงู† ุงูุถู„ ุฎูŠุงุฑ ู„ู„ุถุบุท ููŠ ูƒุจุงุฑ ุงู„ุณู† ู‡ูˆ CCB ูˆู„ูŠุณ ุงู„ACEi ู„ุงู†ูƒ ุถุฑุจุช ุนุตููˆุฑูŠู† ุจุญุฌุฑ๐Ÿ‘Œ


ุงู„ุตูˆุฑุฉ ู„ุชูˆุถูŠุญ ุงู„ุขู„ูŠุฉ( ุงู„ููŠุณูˆู„ูˆุฌูŠ) ูˆุงู†ู‡ ู…ู† ุฎู„ุงู„ ุงู„ู†ูˆุน AT2,AT4.ูˆูƒู„ุงู… ูƒุซูŠุฑ ุจุณ ุฌุจู†ุง ุงู„ุฎู„ุงุต.
#Basel
https://t.me/pharma_Note
๐Ÿ‘5๐Ÿ”ฅ1
๐Ÿ›‘Captopril oral liquid๐Ÿค”

โ™ฆุณุคุงู„ ูƒูŠู ูŠู…ูƒู† ุงู† ู†ุนุทู‰ ุฌุฑุนุฉ ู…ู‚ุฏุงุฑฺพุง 2mg ู„ุทูู„ ู…ู† ุนู„ุงุฌ ุงู„ูƒุงุจูˆุชูŠู† captopril ุนู„ู…ุง ุงู† ุงู„ู…ุชูˆูุฑ ฺพูˆ ูู‚ุท
ุงู‚ุฑุงุต ุจู‚ูˆุฉ 25mg ูˆ 50mg ูˆู„ุง ูŠุชูˆูุฑ ุฃูŠ ุดูƒู„ ุตูŠุฏู„ุงู†ูŠ ุบูŠุฑฺพุง ู…ู†ุงุณุจ ู„ู„ุฃุทูุงู„ุŒฺพู„ ุชูˆุฌุฏ ุทุฑูŠู‚ุฉ ู…ู†ุงุณุจุฉ ุŸ

ู†ุนู… ูŠูˆุฌุฏ ุทุฑูŠู‚ุฉ ูˆู‡ูŠ ุฎุงุตุฉ ู„ุจุนุถ ุงู„ุฃุฏูˆูŠุฉ ูˆุชุณู…ู‰..
extemporaneous preparation
ูˆู‡ู†ุง ุจุชุชู… ุจุซู„ุงุซ ู…ูˆุงุฏ ฺพูŠ :

โœ…ุงุฑุจุน ุญุจุงุช 25mg captopril ุงูˆ ุญุจุชูŠู† ู‚ูˆุฉ 50mg
โœ…ู‚ุฑุต ููŠุชุงู…ูŠู† ุณูŠ vitamin c ุจู‚ูˆุฉ 500mg

โœ…ู…ุงุก ู…ู‚ุทุฑ
100ml distilled Water

โœ…ุทุฑูŠู‚ุฉ ุงู„ุชุญุถูŠุฑ ฺพูŠ : ุทุญู† ุญุจุงุช ุงู„ูƒุงุจูˆุชูŠู† ู…ุน ููŠุชุงู…ูŠู† ุณูŠ ููŠ mortar ุญุชู‰ ูŠุชุญูˆู„ ุงู„ู‰ a fine powder ุซู… ุชุถุงู ูƒู…ูŠุฉ ู‚ู„ูŠู„ุฉ ู…ู† ุงู„ู…ุงุก ุงู„ู…ู‚ุทุฑ ุญุชู‰ ูŠุญุฏุซ
a smooth paste
ุซู… ุชุถุงู ูƒู…ูŠุฉ ุงุฎุฑู‰ ู…ู† ุงู„ู…ุงุก ุงู„ู…ู‚ุทุฑ ูˆุชู†ู‚ู„ ู…ู† ุงู„ู…ูˆุฑุชุฑ ุงู„ู‰ ุงู„ู‚ู†ูŠู†ุฉ container ุซู… ุชุถุงู ูƒู…ูŠุฉ ุงุฎุฑู‰ ุงู„ู‰ ุงู† ู†ูƒู…ู„ 100ml ู…ู† ุงู„ู…ุงุก ุงู„ู…ู‚ุทุฑ ุงู„ู‰ ุงู„ู…ูˆุฑุชุฑ mortar ูˆุชุฑุฌ shake ูˆู†ุถูŠูฺพุง ุงู„ู‰ ุงู„ู‚ู†ูŠู†ุฉ ููŠุชุญุตู„ ุนู†ุฏู†ุง 100mg ู…ู† ุงู„ูƒุงุจูˆุชูŠู† ููŠ 100ml ู…ู† ุงู„ู…ุงุก ุงู„ู…ู‚ุทุฑ ุฃูŠ ูƒู„ 1ml ูŠุญุชูˆูŠ 1mg ูุชูƒูˆู† ุฌุฑุนุฉ ุงู„ุทูู„ ฺพูŠ 2ml ุจุงู„ูŠูˆู…

โœ…ุนู„ู…ุง ุงู† ุฌุฑุนุฉ ุงู„ูƒุงุจูˆุชูŠู† ู„ู„
Children and Adolescents: Oral: Initial: 0.3 to 0.5 mg/kg/dose every 8 to 12 hours; titrate as needed; in clinical trials, usual reported dosage range was 0.9 to 3.9 mg/kg/day in divided doses; maximum daily dose: 6 mg/kg/day.

โœ…ุงุฎูŠุฑุง ุงู„ุซุจุงุชูŠุฉ:
refrigerate
Stable for 56 days refrigerated or 28 days (ascorbic acid tablet) at room temperature.


#Basel
https://t.me/pharma_Note
๐Ÿ‘4๐Ÿ‘3โค2
โœ…ู…ู‡ู… ุฌุฏุง ุงูŠ ุดุฎุต ู‚ุจู„ ู…ุง ูŠุจุฏุฃ ุงุณุชุฎุฏุงู… ุงุฏูˆูŠุฉ ุงู„alpha blocker ูˆุฎุงุตุฉ ุงู„tamsulosin ู†ู†ุธุฑ ุงู† ูƒุงู† ูŠุฎุทุท ู„ุนู…ู„ ุนู…ู„ูŠุฉ ุฅุฒุงู„ุฉ ุงู„ู…ูŠุงุฉ ุงู„ุจูŠุถุงุก..
ุงู† ูƒุงู† ุจูŠุนู…ู„ู‡ุง ูู‡ูŠ ุงูˆู„ุงู‹ ุซู… ุจุนุฏู‡ุง ูŠุณุชุฎุฏู… ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ู„ู…ู†ุน intraoprative floppy iris syndrome( IFIS)

โœ…ุงู† ูƒุงู† ุจูŠุณุชุฎุฏู…ู‡ุง ูˆุญุตู„ ูˆุจูŠุนู…ู„ ุนู…ู„ูŠุฉ ูŠุฌุจ ุงุฎุจุงุฑ ุงุฎุตุงุฆูŠ ุงู„ุนูŠูˆู† ู‚ุจู„ ุงู„ุนู…ู„ูŠุฉ ู„ุชู‚ู„ูŠู„ ุงู„ู…ุฎุงุทุฑ ูˆุงุชุฎุงุฐ ุงู„ุฅุฌุฑุงุก ุงู„ู…ู†ุงุณุจุŒ ูƒุตุฑู NSAID

โœ…ู…ู† ุงุณู…ู‡ุง ุจุฎุชุตุงุฑ ุชุนู†ูŠ.. ุญุตู„ ุชุฑู‡ู„ ูˆุงู†ุชูุงุฎ ู„ุญุฏู‚ุฉ ุงู„ุนูŠู† ุงุซู†ุงุก ุงู„ุนู…ู„ูŠุฉ..
ูˆู‚ุฏ ุชุญุตู„ ููŠ ูƒู„ %2 ุงู„ู‰ %3 ู…ู† ุงู„ู…ุฑุถู‰.

โœ…ู„ุง ุชุญู„ ุจุชูˆู‚ูŠู ุงู„ุฏูˆุงุก ุญุชู‰ ุจุนุฏ ุณู†ูˆุงุช ู…ู† ุงูŠู‚ุงูู‡ุง.

#Basel
https://t.me/pharma_Note
๐Ÿฅฐ3
โœ…ู„ู„ู…ู‡ุชู…ูŠู† ุจุฃุฏูˆูŠุฉ ุงู†ู‚ุงุต ุงู„ูˆุฒู† ูˆ ู…ุณุชุฌุฏุงุชู‡ุง , ู…ู„ุฎุต ู„ูƒู„ ู…ุง ูŠุฎุต ุงุฏูˆูŠุฉ ุงู†ู‚ุงุต ุงู„ูˆุฒู† , ู…ู†ู‚ูˆู„ ู…ู† ุฃุฎุฑ ุชูˆุตูŠุงุช ู…ู†ุดูˆุฑุฉ ู‡ุฐุง ุงู„ุดู‡ุฑ ู…ู† ุงู„ American Association of Clinical Endocrinology 2023

https://t.me/pharma_Note
โค3
๐ŸŸฅ New Updated 2023
AGS Beers criteria๐Ÿ‘†.
โœ…ู„ุฐู„ูƒ ู„ูˆ ูƒุงู† ุงู„ุดุฎุต ู…ุงุดูŠ ุน HCTZ ูˆู„ุง ุฒุงู„ uncontrolled hypertension ูŠุญูˆู„ ุงู„ู‰ chlorthalidone ู„ุงู† ูุนุงู„ูŠุชู‡ ููŠ ุชู‚ู„ู„ ุงู„ุถุบุท ุงูƒุจุฑ ู…ู† ุญูŠุซ CVS event ูู‡ู… equal.
#Basel
https://t.me/pharma_Note
๐Ÿ‘7๐Ÿคฏ1
โœ…ููŠ ู…ุนุงู„ุฌุฉ ุชุถุฎู… ุงู„ุจุฑูˆุณุชุงุชุง BPH ุงู„ู…ุฑุดุญูŠู† ู„ุฃุฎุฐ ุฃุฏูˆูŠุฉ
5alpha reductase inhibitors
ู…ุซู„ ุงู„
(Finasteride ุงูˆ dutasteride)

โœ…ู…ู‡ู… ุฌุฏุงู‹ ู‚ูŠุงุณ baseline ู„ู„(PSA) ุซู… ุงู„ุชู‚ูŠูŠู… ุงูŠ ุงุนุงุฏุฉ ุงู„ูุญุต ุจุนุฏ 6 ุงุดู‡ูˆุฑ
ุงุฐุง ู„ู… ูŠู‚ู„ ุงู„PSA ุนู† ุงู„ู‚ูŠู…ุฉ ุงู„ุฃูˆู„ูŠุฉ ู„ู‡ (baseline) ุนู† %50 ูˆุจุนุฏ ุงุณุชุจุนุงุฏ ุงู„ุชุฒุงู… ุงู„ู…ุฑูŠุถ ู„ุฃุฎุฐ ุงู„ุฏูˆุงุก.
Then should be evaluated for prostate cancer.


#Basel
https://t.me/pharma_Note
โœ…Hyperemesis Gravidarum during pregnancy.


โœ…Can be treated by Dpamine antagonists:
โ—‹ Metoclopramide 5โ€“10 mg PO/IM/IV every eight hours

โœ… details see special note ๐Ÿ‘‡


#Basel
https://t.me/pharma_Note
๐Ÿ‘1
โœ…statin associated muscle symptom (SAMS)

โœ…ู…ู† ุงุดูŠุน ู…ุดุงูƒู„ ุฃุฏูˆูŠุฉ ุงู„ุณุชุงุชูŠู† ู‡ูŠ ูˆู‡ู† ุงู„ุนุถู„ุงุช ุจุงู„ุงุถุงูุฉ ุงู„ู‰ ุชุฃุซูŠุฑู‡ุง ุน ุงู„ูƒุจุฏ ูˆุชุตู†ู ู„ุนุฏุฉ ู…ุตุทู„ุญุงุช ูˆู…ุฑุงุญู„ ุชุตู„ ุงู„Rhabdomyolysis ูˆุงูŠู‚ุงู ุงู„ุฏูˆุงุก

ู„ุฐู„ูƒ ู„ุงุฒู… ู†ุญุณุจ SAMS CI SCOR ู†ุญุณุจ ุงู„ุงุณูƒูˆุฑ ูˆู†ู…ุดูŠ ุนู„ูŠู‡.

โœ…For patients with a low SAMS-CI score (2 to 4):

โ€ขDiscontinue the statin.

โ€ขEvaluate for other causes of symptoms, including depression and anxiety or medication-related side effects.

โ€ขWait for symptom resolution.

After symptom resolution:

โœ…IF patient was not on a high-intensity statin, restart the same statin at a lower dose

โœ… IF the patient was on a high-intensity statin, switch to an alternative high-intensity statin (atorvastatin, rosuvastatin) and address concerns about side effects.

โœ… IF the patient experiences adverse muscle symptoms on the alternative high-intensity statin, we recommend switching to fluvastatin, pravastatin, or pitavastatin.

โœ… IF the patient was already on a low daily dose of a statin, consider alternate-day dosing 'Alternate-day dosing



#ูŠุชุจุน..
https://t.me/pharma_Note
๐Ÿ‘3
โœ…For patients with a high SAMS-CI score (5 to 11):

โ€ขDiscontinue the statin.

โ€ขAssess for drug interactions, including those related to addition of a new medication or a change in administration of a long-term medication that may account for symptoms.

โ€ขAssess for comorbidities which may account for or exacerbate symptoms (vitamin D deficiency, hypothyroidism, acute or chronic renal failure, or obstructive liver disease). Correct hypothyroidism or low vitamin D level if present.

After symptom resolution:

โœ…IF patient was not on a high-intensity statin, restart the same statin at same or lower dose. If patient was already on the lowest dose, consider alternate-day dosing, although this may result in lower efficacy. Alternate-day dosing

โœ…IF patient was on a high-intensity statin, switch to an alternative high-intensity statin (atorvastatin, rosuvastatin) and address concerns about side effects. If the patient experiences adverse muscle symptoms on the alternative high-intensity statin, we recommend switching to fluvastatin, pravastatin, or pitavastatin.

#ูŠุชุจุน..
โœ…Readminister the SAMS-CI between 4 and 12 weeks.

โœ…IF SAMS-CI score is still high, switch to a statin with different pharmacokinetic properties and/or consider non-statin low-density lipoprotein (LDL) cholesterol-lowering therapy.

โœ…IF switching statin therapy to an agent with a different pharmacokinetic profile is unsuccessful initiate alternate-day (or less frequent) dosing with careful monitoring. Alternate-day dosing.

โœ…IF SAMS-CI score is low, consider and evaluate for non-statin-associated conditions or therapies that may be causing symptoms.

โœ…IF symptoms persist, discontinue all statin therapy and consider non-statin cholesterol-lowering


#Basel
https://t.me/pharma_Note